attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention 1: Intervention group: Underwent atomoxetine (40 mg daily) and diet including essential amino acids, B vitamins, vitamin C and iron and zinc minerals Treatment. Intervention 2: Control gr
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to 16 Months
Inclusion criteria
Inclusion criteria: Age 7 to 16 years No neurological or organic disorder
Exclusion criteria
Exclusion criteria: Lack of compliance Patients on a special diet
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in disease symptoms. Timepoint: Before starting treatment and 8 months after starting treatment. Method of measurement: with the SWAN and Conners questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the child's strengths and weaknesses. Timepoint: Before and 8 months after treatment starting. Method of measurement: with the SDQ questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Moradi
Hamedan University of Medical Sciences
Outcome results
None listed